Skip to main content
Back to feed
MarketsSingle-sourceLow
2.0

Sunshine Biopharma Inc. reports executive or director departure/appointment

Sunshine Biopharma Inc. filed an 8-K disclosing changes to its board of directors or executive leadership under Item 5.02. The filing details the departure or appointment of key personnel, which is a standard corporate governance disclosure.

SEC EDGAR 8-K Filingsabout 4 hours agoUSengCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

#sec#8-k#corporate-governance#biopharma

Entities

country
Source

Related signals

8 found